Anti-aging Efficacy of Food Supplement and Cosmetic Routine
In&Out
Anti-aging Efficacy Study With Food Supplement and Cosmetic Routine vs Placebo
1 other identifier
interventional
72
1 country
1
Brief Summary
The aim of this study is to investigate the impact of a topical and an oral product alone and in combination compared to placebo on skin aging
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedStudy Start
First participant enrolled
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2025
CompletedJuly 25, 2025
July 1, 2025
3 months
April 10, 2025
July 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Anti-wrinkle efficacy
Change from baseline in anti-wrinkles efficacy (assessed on three-dimensional structure of the wrinkles in the periorbital regions) after 6 and 12 weeks. Anti-wrinkle efficacy will be assessed using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).
12 weeks
Secondary Outcomes (7)
Skin barrier function
12 weeks
Skin hydration
12 weeks
Skin firmness
12 weeks
Skin elasticity
12 weeks
Wrinkles and fine lines
12 weeks
- +2 more secondary outcomes
Study Arms (4)
Food supplement and cosmetic routine
EXPERIMENTALThe "food supplement and cosmetic routine" arm will consume the food supplement active and apply the skin care product active.
Food supplement
EXPERIMENTALThe "food supplement" arm will consume the food supplement active and apply the skin care product placebo.
Cosmetic routine
EXPERIMENTALThe "cosmetic routine" arm will consume the food supplement placebo and apply the skin care product active.
Placebo
PLACEBO COMPARATORThe "placebo" arm will consume the food supplement placebo and apply the skin care product placebo.
Interventions
The food supplement active (2 soft gels) will be consumed once per day with a large glass of water.
The food supplement placebo (2 soft gels) will be consumed once per day with a large glass of water.
The cosmetic skin care product active will be applied twice daily to half of the face and to one volar forearm.
The cosmetic skin care product placebo will be applied twice daily to half of the face and to one volar forearm.
Eligibility Criteria
You may qualify if:
- Written Informed Consent to participate in the study
- Willingness to actively participate in the study and to come to the scheduled visits
- Female
- From 40 to 70 years of age, in order to include sufficient subjects for the study, if necessary, the age may be gradually increased to 70 years or decreased to 40 years
- Healthy skin in the test areas
- Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)
- For biopsy subpanel:
- \- Vaccination of tetanus within the last 10 years
You may not qualify if:
- Female subjects: Pregnancy or lactation
- Drug addicts, alcoholics
- AIDS, HIV-positive or infectious hepatitis
- Conditions which exclude a participation or might influence the test reaction/evaluation
- Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
- Active skin disease at the test area
- Documented allergies to face/eye care products and food supplements or their ingredients
- Intake of dietary supplements within the last 3 months before the start of the study
- Diabetes mellitus
- Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
- Epilepsy
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
- Regular use of tanning beds
- Any topical medication at the test area within the last 3 days prior to the start of the study
- Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or within the last 7 days prior to the start of the study
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amazentis SAlead
- SGS proderm GmbHcollaborator
Study Sites (1)
SGS proderm GmbH
Schenefeld, Hamburg, 22869, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Katrin Unbereit
SGS proderm GmbH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2025
First Posted
April 17, 2025
Study Start
April 23, 2025
Primary Completion
July 17, 2025
Study Completion
July 17, 2025
Last Updated
July 25, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share